Pre-made Sonelokimab benchmark antibody (Bispecific, anti-ALB;IL17A/IL17;IL17F therapeutic antibody, Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-996

Pre-made Sonelokimab benchmark antibody (Bispecific, anti-ALB;IL17A/IL17;IL17F therapeutic antibody, Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-996-1mg 1mg Inquiry
GMP-Bios-INN-996-10mg 10mg Inquiry
GMP-Bios-INN-996-100mg 100mg Inquiry
GMP-Bios-INN-996-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Sonelokimab Biosimilar, Bispecific, Anti-ALB;IL17A/IL17;IL17F Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1 therapeutic antibody
INN Name Sonelokimab
TargetALB;IL17A/IL17;IL17F
FormatBispecific
Derivation
Species Reactivity
CH1 Isotype
VD LC
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech